Home From Drew Altman

From Drew Altman

Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

View full bio | Read Dr. Altman's Beyond the Data columns

Photo of Drew Altman

President’s Message

“KFF is an independent source of health policy research, polling, and journalism. We have four major program areas: KFF Policy; KFF Polling; KFF Health News (formerly Kaiser Health News); and KFF Social Impact Media, which conducts specialized public health information campaigns. Learn more about the organization. 

What’s unique about KFF, however, can’t be found in any description of our programs because we’re more than a sum of our parts. KFF is a one-of-a-kind information organization. Not a policy research organization. Not a polling organization. And not a news organization. But rather, a unique combination of all three. That’s the vision behind KFF, and it's this combination that allows us to leverage our combined expertise and assets to play our national role on health policy.” Read more

Beyond the Data

In his “Beyond the Data” columns, Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

The Semi-Sad Prospects for Controlling Employer Health Care Costs

In a commentary on KFF’s 27th employer health benefits survey, President and CEO Dr. Drew Altman discusses the obstacles employers face trying to control their health care costs, and the reasons why they’ve never been meaningful supporters of government cost-containment efforts. He predicts that premium increases expected next year could lead to a new wave of higher deductibles and other forms of cost sharing for the 155 million Americans who rely on employer coverage. Read the column here.

View All Beyond the Data Columns

View the Latest: From Drew Altman

Filter

List Grid

61 - 70 of 327 Results

  • Joe Biden’s New Health Care Agenda (and CMS’s Big Role In It)

    From Drew Altman

    With the Georgia runoff elections giving Democrats control of the U.S. Senate, Drew Altman discusses President-elect Biden’s potential health care agenda and suggests that the Centers for Medicare & Medicaid Services could have an expanded role and that it may be time to rename it and elevate it to a cabinet agency.

  • Joe Biden’s Big Lead on Health Care Issues

    From Drew Altman

    In an Axios column, Drew Altman discusses how this election year health isn’t a single issue -- but several -- and Joe Biden has the edge over President Trump on all of them, even as opposition to the ACA remains popular with Trump’s base.  

  • Black Americans Are More Skeptical of a Coronavirus Vaccine

    From Drew Altman

    Drew Altman discusses how systemic racism has led to striking levels of reluctance to get a COVID-19 vaccine among Black Americans, including those at highest risk, and the challenge it presents for ending the pandemic.

  • Drugs Aren’t the Reason the U.S. Spends So Much on Health Care

    From Drew Altman

    Drew Altman’s column in Axios: the U.S. now spends twice per capita what other wealthy countries do on health care. But while drug costs get all the time in public debate, it's hospital and outpatient spending that mostly explains the difference. And that will be impossible to take on without real pain and political risk, he says.

  • Biden vs Trump on Health With Swing Voters

    From Drew Altman

    Drawing on newly released KFF/Cook Political Report polling in key Sun Belt states, Drew Altman discusses how the 2020 election is more about President Trump but issues do matter. He says that swing voters in Florida, Arizona and North Carolina prefer Joe Biden over President Trump on more issues including health care and the coronavirus, but President Trump has the edge on their top issue, the economy. 

  • Understanding the US Failure on Coronavirus

    From Drew Altman

    For The BMJ, Drew Altman discusses two fundamental policy decisions made by the Trump administration that set the U.S. on the controversial and highly criticized course it has taken on COVID-19.

  • Pharmacies, Not the Military, Will Handle COVID-19 Vaccinations

    From Drew Altman

    President Trump has conjured up the image of a top general and the military delivering the coronavirus vaccine drawing on their vast logistical experience. In his latest Axios column, Drew Altman explains why vaccine realities will dictate that it’s much more likely to be at your local Walgreens or CVS pharmacy.